Medtronic (MDT) Stock Could Be A Bargain On Cash Flow

Medtronic has delivered a solid 51.6% share price gain over the past three years, while rolling out new cardiac devices and digital tools that could reshape how it earns and collects cash. With the stock around US$95.41, the open question is whether that price tag lines up with what the company’s cash flows can reasonably support. The 51.6% return over three years puts real weight on the issue of whether Medtronic’s current valuation can still be explained by its underlying cash...